HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA budget

This article was originally published in The Rose Sheet

Executive Summary

President Clinton signs FDA appropriations bill as part of $520 bil. omnibus package of eight spending bills Oct. 21. The Senate approved HR 4328 by 65-29 on the same day after the House passed the measure 333-95 on Oct. 20. As expected, the bill increases FDA's Office of Cosmetics & Colors' budget by $2.5 mil. The FDA appropriations bill was folded into the omnibus measure after Clinton vetoed the FDA/Agriculture appropriations bill Oct. 8 ("The Rose Sheet" Oct. 12, p. 9). Congress expects the agency to publish a proposed rule concerning the use of foreign marketing data in the review of new sunscreen active ingredients no later than June 1, 1999. FDA salaries and expenses totaled $1.10 bil

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005943

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel